1-3 of 3
Xiaoqiao Jiang
Close
Sort by
Journal Articles

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD
Journal: Blood
Blood (2016) 128 (22): 80.
https://doi.org/10.1182/blood.V128.22.80.80
Published: 2016
Journal Articles

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Subramanian Yegneswaran, PhD, Xiaoqiao Jiang, BS, Pooja Yesantharao, Ji-Yun Kim, PhD, Lilley Leong, PhD MS, Derek S Sim, PhD, Chandra Patel, PhD, Katalin Zsofia Kauser, PhD MD DSc
Journal: Blood
Blood (2014) 124 (21): 1492.
https://doi.org/10.1182/blood.V124.21.1492.1492
Published: 2014
Journal Articles

Waveform Analysis Extends the Capabilities of aPTT and PT Clotting Assays for Detecting Factor Deficiency and Monitoring Procoagulant Drug Therapy

Lilley Leong, PhD, MS, Xiaoqiao Jiang, BS, Jill Cifrese, MS, John E. Murphy, PhD, Jesper Haaning, PhD, Timothy Myles, PhD
Journal: Blood
Blood (2011) 118 (21): 1205.
https://doi.org/10.1182/blood.V118.21.1205.1205
Published: 2011